Loading...
Loading...

by Cadila Pharmaceuticals Ltd· 1S
SKU: 860169
You save ₹573 on this order
Inclusive of all taxes
BORTECAD 2.5MG INJECTION contains Bortezomib, which belongs to the group of
medicines called Antineoplastic agents. It is used in adult patients alone or
with pegylated liposomal doxorubicin/dexamethasone to manage progressive
multiple myeloma when anticancer therapy or hematopoietic stem cell
transplantation becomes unsuitable to manage the disease.
BORTECAD 2.5MG INJECTION is also used in adult patients with rituximab,
cyclophosphamide, doxorubicin, and prednisone to manage unmanageed mantle cell
lymphoma when hematopoietic stem cell transplantation becomes unsuitable to
manage the disease.
Multiple myeloma is a type of cancer that occurs in plasma cells (white blood
cells) and is generally characterized by symptoms such as bone pain, nausea,
constipation, and loss of appetite. Mantle Cell Lymphoma is a rare form of
cancer that affects the lymphatic system and is generally characterized by
symptoms such as loss of appetite, fever, nausea, and/or vomiting.
Your doctor may advise you to do regular blood tests to check your blood counts
before and during management with BORTECAD 2.5MG INJECTION. It is not
recommended for use in patients with severe lung or heart disease.
Before receiving BORTECAD 2.5MG INJECTION, inform your doctor if you have
bleeding problems, diarrhea, constipation, nausea or vomiting, shortness of
breath or cough, seizures, congestive heart failure, mild or moderate renal
impairment, and/or moderate or severe liver impairment.
BORTECAD 2.5MG INJECTION is not recommended for use by pregnant and
breastfeeding women. BORTECAD 2.5MG INJECTION is also not indicated for use in
children and adolescents (below 18 years of age).
The most common side effects of receiving BORTECAD 2.5MG INJECTION are
dizziness, increased heartbeat, sweating, abnormal vision, paresthesia (burning
or pickling sensation), muscle pain, and headache. Inform your doctor if any of
the symptoms worsen during or after management with BORTECAD 2.5MG INJECTION.
Used in adults:
BORTECAD 2.5MG INJECTION works by inhibiting proteasomes (enzymes responsible
for breaking down proteins into smaller compounds for cells), which leads to
imbalance in the cancer cell, thus resulting in its destruction and thereby
managing multiple myeloma and mantle cell lymphoma in affected individuals.
BORTECAD 2.5MG INJECTION will be given to you only by a doctor or a nurse into a
vein as an intravenous infusion or into the skin as a subcutaneous injection.
Your doctor will decide the correct dose and duration of BORTECAD 2.5MG
INJECTION for you depending upon your age, body weight, and disease condition.
Stop receiving BORTECAD 2.5MG INJECTION and contact your doctor immediately if
you experience any of the following side effects:
!### Constipation
Eat more fiber-rich foods, especially soluble fibers. Keep yourself hydrated.
Inform your doctor if the symptoms do not improve.
!### Diarrhea
Drink a lot of fluids, such as water or fruit juices, to keep yourself hydrated.
Inform your doctor if the symptoms do not improve.
Rest and relax. Drink plenty of fluids, such as water or electrolytes. Apply a
pain-relieving balm to the head if required. Do not consume alcohol. Inform your
doctor if the symptoms do not improve.
!### Nausea And Vomiting
Stick to simple meals. Avoid eating oil-rich or spicy foods. Inform your doctor
if the symptoms do not improve.
!### Stomach Pain
Try to rest and relax. Eat and drink slowly or try to have smaller and more
frequent meals. Keep a heat pad on your stomach. If the symptoms do not improve,
contact your doctor.
!### Pregnancy
Consult your doctorBORTECAD 2.5MG INJECTION is not recommended for use during pregnancy or by women
planning for pregnancy. It should be used with caution in women with
childbearing potential who should use effective contrace
receiving BORTECAD 2.5MG INJECTION.
!### Breastfeeding
ContraindicatedBORTECAD 2.5MG INJECTION is not recommended for use by breastfeeding women.
Consult your doctor before receiving BORTECAD 2.5MG INJECTION.
!### Driving and Using Machines
Use with CautionDo not drive or operate any machines if you feel dizzy, tired, syncope
(fainting), and/or blurred vision after receiving BORTECAD 2.5MG INJECTION.
!### Kidney
Use with CautionBORTECAD 2.5MG INJECTION should be used with caution in patients with kidney
problems such as mild to moderate renal impairment. Consult your doctor before
receiving BORTECAD 2.5MG INJECTION.
!### Liver
Use with CautionBORTECAD 2.5MG INJECTION should be used with caution in patients with moderate
or severe liver problems, such as hepatic impairment. Consult your doctor before
receiving BORTECAD 2.5MG INJECTION.
!### Allergy
ContraindicatedDo not receive BORTECAD 2.5MG INJECTION if you are allergic to bortezomib,
boron, or any other ingredients of this medicine. Consult your doctor before
receiving BORTECAD 2.5MG INJECTION.
!### Lungs
Consult your doctorBORTECAD 2.5MG INJECTION is not recommended for use in patients with severe lung
problems. It should be used with caution in patients with hepatitis B virus
disease. Consult your doctor before receiving BORTECAD 2.5MG INJECTION.
!### Heart Disease
Consult your doctorBORTECAD 2.5MG INJECTION is not recommended for use if you have severe heart
problems. BORTECAD 2.5MG INJECTION should be used with caution in patients
suffering from heart problems such as congestive heart failure. Consult your
doctor before receiving BORTECAD 2.5MG INJECTION.
!### Use In Pediatrics
ContraindicatedBORTECAD 2.5MG INJECTION is generally not recommended for use in children and
adolescents (aged below 18 years). Consult your child’s doctor for advice before
administering BORTECAD 2.5MG INJECTION to your child.
!### Use In Geriatrics
Use with CautionBORTECAD 2.5MG INJECTION should be used with caution in elderly patients (aged
65 years and above). Consult your doctor before receiving BORTECAD 2.5MG
INJECTION.
Before receiving BORTECAD 2.5MG INJECTION, inform your doctor if you have:
A. Drug-Drug interactions:
Before taking BORTECAD 2.5MG INJECTION, inform your doctor if you are taking any
of the following medicines:
Overdosage:
BORTECAD 2.5MG INJECTION will be administered to you only by a doctor or a nurse
in a hospital, and so you are unlikely to receive an overdose. However, consult
your doctor if you experience any unusual symptoms of BORTECAD 2.5MG INJECTION,
such as the acute onset of symptomatic hypotension (low blood pressure while
standing up from a lying position) and thrombocytopenia (a condition marked by a
low platelet count).
| Drug | : | Bortezomib |
| Pharmacological Category | : | Anti-neoplastic agent |
| Therapeutic Indication | : | Multiple myeloma, Mantle cell Lymphoma |
| Dosage Forms | : | Injection |
Q: How is BORTECAD 2.5MG INJECTION administered?
A: BORTECAD 2.5MG INJECTION will be given to you only by a doctor or a nurse
into a vein as an intravenous infusion or into the skin as a subcutaneous
injection. Your doctor will decide the correct dose and duration of BORTECAD
2.5MG INJECTION for you depending upon your age, body weight, and disease
condition.
Q: Can BORTECAD 2.5MG INJECTION be used during pregnancy?
A: BORTECAD 2.5MG INJECTION is not recommended for use during pregnancy or by
women planning for pregnancy. It should be used with caution in women with
childbearing potential who should use effective contrace
receiving BORTECAD 2.5MG INJECTION.
Q: Who should avoid receiving BORTECAD 2.5MG INJECTION?
A: BORTECAD 2.5MG INJECTION is not recommended for use in patients with severe
lung and liver problems, and it is also not recommended for use in pregnant and
breastfeeding women. BORTECAD 2.5MG INJECTION is also not indicated for use in
children and adolescents (below 18 years of age). Consult your doctor before
receiving BORTECAD 2.5MG INJECTION.
Q: Can I drive after receiving BORTECAD 2.5MG INJECTION?
A: Do not drive after receiving BORTECAD 2.5MG INJECTION since it may cause
dizziness, tiredness, syncope (fainting), and/or blurred vision, which may
affect your ability or concentration to drive. Consult your doctor before
receiving BORTECAD 2.5MG INJECTION.
Q: Can BORTECAD 2.5MG INJECTION be used in patients with liver problems?
A: BORTECAD 2.5MG INJECTION should be used with caution in patients with
moderate or severe liver problems, such as hepatic impairment. Consult your
doctor before receiving BORTECAD 2.5MG INJECTION.
BORTECAD 2.5MG INJECTION contains Bortezomib, which belongs to the group of
medicines called Antineoplastic agents. It is used in adult patients alone or
with pegylated liposomal doxorubicin/dexamethasone to manage progressive
multiple myeloma when anticancer therapy or hematopoietic stem cell
transplantation becomes unsuitable to manage the disease.
BORTECAD 2.5MG INJECTION is also used in adult patients with rituximab,
cyclophosphamide, doxorubicin, and prednisone to manage unmanageed mantle cell
lymphoma when hematopoietic stem cell transplantation becomes unsuitable to
manage the disease.
Multiple myeloma is a type of cancer that occurs in plasma cells (white blood
cells) and is generally characterized by symptoms such as bone pain, nausea,
constipation, and loss of appetite. Mantle Cell Lymphoma is a rare form of
cancer that affects the lymphatic system and is generally characterized by
symptoms such as loss of appetite, fever, nausea, and/or vomiting.
Your doctor may advise you to do regular blood tests to check your blood counts
before and during management with BORTECAD 2.5MG INJECTION. It is not
recommended for use in patients with severe lung or heart disease.
Before receiving BORTECAD 2.5MG INJECTION, inform your doctor if you have
bleeding problems, diarrhea, constipation, nausea or vomiting, shortness of
breath or cough, seizures, congestive heart failure, mild or moderate renal
impairment, and/or moderate or severe liver impairment.
BORTECAD 2.5MG INJECTION is not recommended for use by pregnant and
breastfeeding women. BORTECAD 2.5MG INJECTION is also not indicated for use in
children and adolescents (below 18 years of age).
The most common side effects of receiving BORTECAD 2.5MG INJECTION are
dizziness, increased heartbeat, sweating, abnormal vision, paresthesia (burning
or pickling sensation), muscle pain, and headache. Inform your doctor if any of
the symptoms worsen during or after management with BORTECAD 2.5MG INJECTION.
Used in adults:
BORTECAD 2.5MG INJECTION works by inhibiting proteasomes (enzymes responsible
for breaking down proteins into smaller compounds for cells), which leads to
imbalance in the cancer cell, thus resulting in its destruction and thereby
managing multiple myeloma and mantle cell lymphoma in affected individuals.
BORTECAD 2.5MG INJECTION will be given to you only by a doctor or a nurse into a
vein as an intravenous infusion or into the skin as a subcutaneous injection.
Your doctor will decide the correct dose and duration of BORTECAD 2.5MG
INJECTION for you depending upon your age, body weight, and disease condition.
Stop receiving BORTECAD 2.5MG INJECTION and contact your doctor immediately if
you experience any of the following side effects:
!### Constipation
Eat more fiber-rich foods, especially soluble fibers. Keep yourself hydrated.
Inform your doctor if the symptoms do not improve.
!### Diarrhea
Drink a lot of fluids, such as water or fruit juices, to keep yourself hydrated.
Inform your doctor if the symptoms do not improve.
Rest and relax. Drink plenty of fluids, such as water or electrolytes. Apply a
pain-relieving balm to the head if required. Do not consume alcohol. Inform your
doctor if the symptoms do not improve.
!### Nausea And Vomiting
Stick to simple meals. Avoid eating oil-rich or spicy foods. Inform your doctor
if the symptoms do not improve.
!### Stomach Pain
Try to rest and relax. Eat and drink slowly or try to have smaller and more
frequent meals. Keep a heat pad on your stomach. If the symptoms do not improve,
contact your doctor.
!### Pregnancy
Consult your doctorBORTECAD 2.5MG INJECTION is not recommended for use during pregnancy or by women
planning for pregnancy. It should be used with caution in women with
childbearing potential who should use effective contrace
receiving BORTECAD 2.5MG INJECTION.
!### Breastfeeding
ContraindicatedBORTECAD 2.5MG INJECTION is not recommended for use by breastfeeding women.
Consult your doctor before receiving BORTECAD 2.5MG INJECTION.
!### Driving and Using Machines
Use with CautionDo not drive or operate any machines if you feel dizzy, tired, syncope
(fainting), and/or blurred vision after receiving BORTECAD 2.5MG INJECTION.
!### Kidney
Use with CautionBORTECAD 2.5MG INJECTION should be used with caution in patients with kidney
problems such as mild to moderate renal impairment. Consult your doctor before
receiving BORTECAD 2.5MG INJECTION.
!### Liver
Use with CautionBORTECAD 2.5MG INJECTION should be used with caution in patients with moderate
or severe liver problems, such as hepatic impairment. Consult your doctor before
receiving BORTECAD 2.5MG INJECTION.
!### Allergy
ContraindicatedDo not receive BORTECAD 2.5MG INJECTION if you are allergic to bortezomib,
boron, or any other ingredients of this medicine. Consult your doctor before
receiving BORTECAD 2.5MG INJECTION.
!### Lungs
Consult your doctorBORTECAD 2.5MG INJECTION is not recommended for use in patients with severe lung
problems. It should be used with caution in patients with hepatitis B virus
disease. Consult your doctor before receiving BORTECAD 2.5MG INJECTION.
!### Heart Disease
Consult your doctorBORTECAD 2.5MG INJECTION is not recommended for use if you have severe heart
problems. BORTECAD 2.5MG INJECTION should be used with caution in patients
suffering from heart problems such as congestive heart failure. Consult your
doctor before receiving BORTECAD 2.5MG INJECTION.
!### Use In Pediatrics
ContraindicatedBORTECAD 2.5MG INJECTION is generally not recommended for use in children and
adolescents (aged below 18 years). Consult your child’s doctor for advice before
administering BORTECAD 2.5MG INJECTION to your child.
!### Use In Geriatrics
Use with CautionBORTECAD 2.5MG INJECTION should be used with caution in elderly patients (aged
65 years and above). Consult your doctor before receiving BORTECAD 2.5MG
INJECTION.
Before receiving BORTECAD 2.5MG INJECTION, inform your doctor if you have:
A. Drug-Drug interactions:
Before taking BORTECAD 2.5MG INJECTION, inform your doctor if you are taking any
of the following medicines:
Overdosage:
BORTECAD 2.5MG INJECTION will be administered to you only by a doctor or a nurse
in a hospital, and so you are unlikely to receive an overdose. However, consult
your doctor if you experience any unusual symptoms of BORTECAD 2.5MG INJECTION,
such as the acute onset of symptomatic hypotension (low blood pressure while
standing up from a lying position) and thrombocytopenia (a condition marked by a
low platelet count).
| Drug | : | Bortezomib |
| Pharmacological Category | : | Anti-neoplastic agent |
| Therapeutic Indication | : | Multiple myeloma, Mantle cell Lymphoma |
| Dosage Forms | : | Injection |
Q: How is BORTECAD 2.5MG INJECTION administered?
A: BORTECAD 2.5MG INJECTION will be given to you only by a doctor or a nurse
into a vein as an intravenous infusion or into the skin as a subcutaneous
injection. Your doctor will decide the correct dose and duration of BORTECAD
2.5MG INJECTION for you depending upon your age, body weight, and disease
condition.
Q: Can BORTECAD 2.5MG INJECTION be used during pregnancy?
A: BORTECAD 2.5MG INJECTION is not recommended for use during pregnancy or by
women planning for pregnancy. It should be used with caution in women with
childbearing potential who should use effective contrace
receiving BORTECAD 2.5MG INJECTION.
Q: Who should avoid receiving BORTECAD 2.5MG INJECTION?
A: BORTECAD 2.5MG INJECTION is not recommended for use in patients with severe
lung and liver problems, and it is also not recommended for use in pregnant and
breastfeeding women. BORTECAD 2.5MG INJECTION is also not indicated for use in
children and adolescents (below 18 years of age). Consult your doctor before
receiving BORTECAD 2.5MG INJECTION.
Q: Can I drive after receiving BORTECAD 2.5MG INJECTION?
A: Do not drive after receiving BORTECAD 2.5MG INJECTION since it may cause
dizziness, tiredness, syncope (fainting), and/or blurred vision, which may
affect your ability or concentration to drive. Consult your doctor before
receiving BORTECAD 2.5MG INJECTION.
Q: Can BORTECAD 2.5MG INJECTION be used in patients with liver problems?
A: BORTECAD 2.5MG INJECTION should be used with caution in patients with
moderate or severe liver problems, such as hepatic impairment. Consult your
doctor before receiving BORTECAD 2.5MG INJECTION.